Book contents
- Androgens in Gynecological Practice
- Androgens in Gynecological Practice
- Copyright page
- Contents
- About the editors
- Dedication
- Contributors
- Preface
- Section 1 Managing the basics
- Section 2 The scientific essentials
- Section 3 Learning from the extremes
- 11 Congenital adrenal hyperplasia in females
- 12 Cushing’s syndrome in females
- 13 Androgen-producing ovarian tumors
- 14 Cognitive and behavioral impact of androgen disorders in females: Learning from complete androgen insensitivity syndrome and congenital adrenal hyperplasia
- 15 Testosterone replacement in the aging male: Lessons learned from the Women’s Health Initiative
- Section 4 The tool kit
- Index
- Plate Section
- References
13 - Androgen-producing ovarian tumors
from Section 3 - Learning from the extremes
Published online by Cambridge University Press: 05 July 2015
Book contents
- Androgens in Gynecological Practice
- Androgens in Gynecological Practice
- Copyright page
- Contents
- About the editors
- Dedication
- Contributors
- Preface
- Section 1 Managing the basics
- Section 2 The scientific essentials
- Section 3 Learning from the extremes
- 11 Congenital adrenal hyperplasia in females
- 12 Cushing’s syndrome in females
- 13 Androgen-producing ovarian tumors
- 14 Cognitive and behavioral impact of androgen disorders in females: Learning from complete androgen insensitivity syndrome and congenital adrenal hyperplasia
- 15 Testosterone replacement in the aging male: Lessons learned from the Women’s Health Initiative
- Section 4 The tool kit
- Index
- Plate Section
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Androgens in Gynecological Practice , pp. 136 - 145Publisher: Cambridge University PressPrint publication year: 2015
References
1.Bailey, AP, Schutt, AK, Carey, RM, et al. Hyperandrogenism of ovarian etiology: utilizing differential venous sampling for diagnosis. Obstet Gynecol 2012; 120: 476–479.CrossRefGoogle ScholarPubMed
2.Azziz, R, Sanchez, IA, Knochenhauer, ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004; 89: 453–462.CrossRefGoogle ScholarPubMed
3.Luton, J-P, Cerdas, S, Billaud, L, et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of Mitotane therapy. N Engl J Med 1990; 322: 1195–1201.CrossRefGoogle ScholarPubMed
5.Tekin, O, Bünyamin, I, Avci, Z, et al. Hirsutism: common clinical problem or index of serious disease? Med Gen Med 2004; 6: 56.Google Scholar
6.Loriaux, DL. An approach to the patient with hirsutism. J Clin Endocrinol Metab 2012; 97: 2957–2968.Google Scholar
7.Practice Committee of the American Society for Reproductive Medicine. The evaluation and treatment of androgen excess. Fertil Steril 2006; 86: S241–S247.Google Scholar
8.Escobar-Morreale, HF, Carmina, E, Dewailly, D, et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update 2012; 18: 146–170.CrossRefGoogle ScholarPubMed
9.Speroff, L, Glass, RH, Kase, NG. Clinical Gynecologic Endocrinology and Infertility, Sixth Edition. Philadelphia: Lippincott Williams & Wilkins, 1999.Google Scholar
10.Rosenfield, RL. Clinical practice. Hirsutism. N Engl J Med 2005; 353: 2578–2588.CrossRefGoogle ScholarPubMed
11.Escobar-Morreale, HF. Diagnosis and management of hirsutism. Ann NY Acad Sci 2010; 1205: 166–174.Google Scholar
12.Surrey, ES, de Ziegler, D, Gambone, JC, Judd, HL. Preoperative localization of androgen-secreting tumors: clinical, endocrinologic, and radiologic evaluation of ten patients. Am J Obstet Gynecol 1988; 158: 1313–1322.Google Scholar
13.Derksen, J, Nagesser, SK, Meinders, AE, et al. Identification of virilizing adrenal tumors in hirsute women. N Engl J Med 1994; 331: 968–973.CrossRefGoogle ScholarPubMed
14.Lobo, RA. Ovarian hyperandrogenism and androgen-producing tumors. Endocrinol Metab Clin North Am 1991; 20: 773–805.CrossRefGoogle ScholarPubMed
15.Levens, ED, Whitcomb, BW, Csokmay, JM, Nieman, LK. Selective venous sampling for androgen-producing ovarian pathology. Clin Endocrinol 2009; 70: 606–614.CrossRefGoogle ScholarPubMed
16.Nishiyama, S, Hirota, Y, Udagawa, Y, et al. Efficacy of selective venous catheterization in localizing a small androgen-producing tumor in ovary. Med Sci Monit 2008; 14: CS9–12.Google Scholar
17.Outwater, EK, Marchetto, B, Wagner, BJ. Virilizing tumors of the ovary: imaging features. Ultrasound Obstet Gynecol 2000; 15: 365–371.Google Scholar
18.Ozgun, MT, Batukan, C, Turkyilmaz, C, et al. Selective ovarian vein sampling can be crucial to localize a Leydig cell tumor: an unusual case in a postmenopausal woman. Maturitas 2008; 61: 278–280.CrossRefGoogle Scholar
19.Demidov, VN, Lipatenkova, J, Vikhareva, O, et al. Imaging of gynecological disease (2): clinical and ultrasound characteristics of Sertoli cell tumors, Sertoli-Leydig cell tumors and Leydig tumors. Ultrasound Obstet Gynecol 2008; 31: 85–91.Google Scholar
20.Annaiah, TK, Webb, B, Buckingham, S. Magnetic resonance imaging: a valuable aid to the diagnosis of a rare ovarian tumour – steroid secreting tumour of the ovary not otherwise specified. J Obstet Gynaecol 2010; 30: 77–78.CrossRefGoogle Scholar
21.Prassopoulos, V, Laspas, F, Vlachou, F, et al. Leydig cell tumour of the ovary localized with Positron Emission Tomography/Computed Tomography. Gynecol Endocrinol 2011; 27: 837–839.Google Scholar
22.Hiromura, T, Nishioka, T, Nishioka, S, et al. Reflux in the left ovarian vein: analysis of MDCT findings in asymptomatic women. Am J Roentgenol 2004; 183: 1411–1415.Google Scholar
23.Sorensen, R, Moltz, L, Schwartz, U. Technical difficulties of selective blood sampling in the differential diagnosis of female hyperandrogenism. Cardiovasc Intervent Radiol 1986; 9: 75–82.CrossRefGoogle ScholarPubMed
24.Dickerson, RD, Putman, MJ, Black, ME, et al. Selective ovarian vein sampling to localize a Leydig cell tumor. Fertil Steril 2006; 84: 19–22.Google Scholar
25.Bohlmann, MK, Rabe, T, Sinn, H-P, et al. Intraoperative venous blood sampling to localize a small androgen-producing ovarian tumor. Gynecol Endocrinol 2005; 21: 138–141.CrossRefGoogle ScholarPubMed
26.Regnier, C, Bennet, A, Malet, D, et al. Intraoperative testosterone assay for virilizing ovarian tumor topographic assessment: report of a Leydig cell tumor of the ovary in a premenopausal woman with an adrenal incidentaloma. J Clin Endocrinol Metab 2002; 87: 3074–3077.CrossRefGoogle Scholar
27.Petersons, CJ, Burt, MG. The utility of adrenal and ovarian venous sampling in the investigation of androgen-secreting tumours. Intern Med J 2011; 41: 69–70.Google Scholar
28.Klotz, RK, Müller-Holzner, E, Fressler, S, et al. Leydig-cell tumor of the ovary that responded to GnRH-analogue administration: case report and review of the literature. Exp Clin Endocrinol Diabetes 2010; 118: 291–297.Google Scholar
29.Chen, VW, Ruiz, BR, Killeen, JL, et al. Pathology and classification of ovarian tumors. Cancer (supplement) 2003; 97: 2631–2642.Google Scholar
30.Sadler, TW. Langman’s Medical Embryology, Fifth Edition. Baltimore: Williams & Wilkins, 2005.Google Scholar
31.Scully, RE. Classification of human ovarian tumors. Environ Health Perspect 1987; 73: 15–24.CrossRefGoogle ScholarPubMed
32.Lee-Jones, L. Ovarian tumours: an overview. Atlas Genet Cytogenet Oncol Haematol 2003. http://AtlasGeneticsOncology.org/Tumors/OvarianTumOverviewID5231.htm (accessed January 25, 2013).Google Scholar
33.Fox, H. Sex cord-stromal tumours of the ovary. J Pathol 1985; 145: 127–148.CrossRefGoogle ScholarPubMed
34.Deavers, MT, Oliva, E, Nucci, M. Sex cord-stromal tumors of the ovary. In: Nucci, MR, Oliva, E, Eds. Gynecologic Pathology: A Volume in Foundations in Diagnostic Pathology. China: Elsevier Churchill Livingstone. 2007; 445–500.Google Scholar
35.Young, RH, Scully, RE. Sex cord-stromal, steroid cell, and other ovarian tumors with endocrine, paraendocrine, and paraneoplastic manifestations. In: Kurman, RJ, Ed. Blaustein’s Pathology of the Female Genital Tract, Fifth Edition. New York: Springer-Verlag, Inc., 2002: 905–966.Google Scholar
36.Sternberg, WH, Dhurandhar, HN. Functional ovarian tumors of stromal and sex cord origin. Hum Pathol 1977; 8: 565–582.Google Scholar
37.Hayes, FJ, Sheahan, K, Rajendiran, MB, McKenna, TJ. Virilization in a postmenopausal woman as a result of hilus cell hyperplasia associated with a simple ovarian cyst. Am J Obstet Gynecol 1997; 176: 719–720.CrossRefGoogle Scholar
38.Ireland, K, Woodruff, JD. Masculinizing ovarian tumors. Obstet Gynecol Surv 1976; 31: 83–111.Google Scholar
39.Cheng, V, Doshi, KB, Falcone, T, Faiman, C. Hyperandrogenism in a postmenopausal woman: diagnostic and therapeutic challenges. Endocr Pract 2011; 17: e21–e25.Google Scholar
40.Picón, MJ, Lara, JI, Sarasa, JL, et al. Use of a long-acting gonadotropin-releasing hormone analogue in a postmenopausal woman with hyperandrogenism due to a hilus cell tumour. Eur J Endocrinol 200; 142: 619–622.Google Scholar
41.Wang, P-H, Chao, H-T, Lee, W-L. Use of a long-acting gonadotropin-releasing hormone agonist for treatment of steroid cell tumors of the ovary. Fertil Steril 1998; 69: 353–355.Google Scholar